Qingdao Haier Biomedical Co Ltd
SSE:688139
Wall Street
Price Targets
Price Targets Summary
Qingdao Haier Biomedical Co Ltd
According to Wall Street analysts, the average 1-year price target for
Qingdao Haier Biomedical Co Ltd
is 66.3 CNY
with a low forecast of 50.5 CNY and a high forecast of 84 CNY.
Operating Income
Forecast
Operating Income Estimate
Qingdao Haier Biomedical Co Ltd
For the last 6 years the
compound annual growth rate for
Qingdao Haier Biomedical Co Ltd's operating income is
32%.
The projected
CAGR
for the next 2 years is
80%.
Net Income
Forecast
Net Income Estimate
Qingdao Haier Biomedical Co Ltd
For the last 6 years the
compound annual growth rate for
Qingdao Haier Biomedical Co Ltd's net income is
37%.
The projected
CAGR
for the next 3 years is
16%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Qingdao Haier Biomedical Co Ltd's stock price target?
Price Target
66.3
CNY
According to Wall Street analysts, the average 1-year price target for
Qingdao Haier Biomedical Co Ltd
is 66.3 CNY
with a low forecast of 50.5 CNY and a high forecast of 84 CNY.
What is Qingdao Haier Biomedical Co Ltd's Revenue forecast?
Projected CAGR
20%
For the last 6 years the
compound annual growth rate for
Qingdao Haier Biomedical Co Ltd's revenue is
24%.
The projected
CAGR
for the next 3 years is
20%.
What is Qingdao Haier Biomedical Co Ltd's Operating Income forecast?
Projected CAGR
80%
For the last 6 years the
compound annual growth rate for
Qingdao Haier Biomedical Co Ltd's operating income is
32%.
The projected
CAGR
for the next 2 years is
80%.
What is Qingdao Haier Biomedical Co Ltd's Net Income forecast?
Projected CAGR
16%
For the last 6 years the
compound annual growth rate for
Qingdao Haier Biomedical Co Ltd's net income is
37%.
The projected
CAGR
for the next 3 years is
16%.
You don't have any saved screeners yet
